Jiangsu Jibeier Pharmaceutical revenue up 7.6% YoY; profit down 33.5%
Jiangsu Jibeier Pharmaceutical reported revenue up 7.6% YoY and net profit down 33.5%. Dividend proposed as its R&D pipeline advanced.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.